4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-23-021910
Chief Executive Officer bought 14,000 shares at $0.53 ($7,420)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2023-06-20 | Purchase | +14,000 | $0.53 | $7,420 | 86,521 | D |
| Open-market purchases · 14,000 sh · avg $0.53 · $7,420 | |||||||
Loading xslF345X04/ownership.xml…